1. Home
  2. Labeler Index
  3. Revance Therapeutics, Inc.
  4. 72960-112
  5. NDC Package Code: 72960-112-01 Daxxify

NDC Package 72960-112-01 Daxxify

Botulinum Toxin Type A Injection, Powder, Lyophilized, For Solution Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
72960-112-01
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 1.2 mL in 1 VIAL, SINGLE-USE
Product Code:
72960-112
Proprietary Name:
Daxxify
Non-Proprietary Name:
Botulinum Toxin Type A
Substance Name:
Botulinum Toxin Type A
Usage Information:
DAXXIFY (daxibotulinumtoxinA-lanm) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
11-Digit NDC Billing Format:
72960011201
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2612454 - daxibotulinumtoxinA-lanm 100 UNT Injection
  • RxCUI: 2612456 - Daxxify 100 UNT Injection
  • RxCUI: 2612456 - daxibotulinumtoxinA-lanm 100 UNT Injection [Daxxify]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Revance Therapeutics, Inc.
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
    • Active Ingredient(s):
  • BOTULINUM TOXIN TYPE A 100 U/1.2mL
    • Pharmacologic Class(es):
  • Acetylcholine Release Inhibitor - [EPC] (Established Pharmacologic Class)
  • Acetylcholine Release Inhibitors - [MoA] (Mechanism of Action)
  • Neuromuscular Blockade - [PE] (Physiologic Effect)
  • Neuromuscular Blocker - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    BLA761127
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    09-20-2022
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    72960-112-021 VIAL, SINGLE-USE in 1 CARTON / 1.2 mL in 1 VIAL, SINGLE-USE
    72960-112-051 VIAL, SINGLE-USE in 1 CARTON / 1.2 mL in 1 VIAL, SINGLE-USE
    72960-112-061 VIAL, SINGLE-USE in 1 CARTON / 1.2 mL in 1 VIAL, SINGLE-USE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 72960-112-01?

    The NDC Packaged Code 72960-112-01 is assigned to a package of 1 vial, single-use in 1 carton / 1.2 ml in 1 vial, single-use of Daxxify, a human prescription drug labeled by Revance Therapeutics, Inc.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intramuscular form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 72960-112 included in the NDC Directory?

    Yes, Daxxify with product code 72960-112 is active and included in the NDC Directory. The product was first marketed by Revance Therapeutics, Inc. on September 20, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 72960-112-01?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 72960-112-01?

    The 11-digit format is 72960011201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-272960-112-015-4-272960-0112-01